BSE - Delayed Quote INR

Sun Pharmaceutical Industries Limited (SUNPHARMA.BO)

1,688.70
+1.70
+(0.10%)
At close: June 13 at 3:55:38 PM GMT+5:30
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Total Revenue
520,412,500
520,412,500
477,584,500
432,788,700
384,264,200
Cost of Revenue
107,473,600
107,473,600
106,626,100
119,424,200
103,515,400
Gross Profit
412,938,900
412,938,900
370,958,400
313,364,500
280,748,800
Operating Expense
287,831,200
287,831,200
266,654,800
220,590,900
199,748,600
Operating Income
125,107,700
125,107,700
104,303,600
92,773,600
81,000,200
Net Non Operating Interest Income Expense
-2,313,600
-2,313,600
-2,384,700
2,125,400
-1,273,500
Pretax Income
137,521,300
137,521,300
110,878,900
94,084,300
44,813,200
Tax Provision
26,338,800
26,338,800
14,394,500
8,475,900
10,755,000
Net Income Common Stockholders
109,290,400
109,290,400
95,763,800
84,735,800
32,727,300
Diluted NI Available to Com Stockholders
109,290,400
109,290,400
95,763,800
84,735,800
32,727,300
Basic EPS
45.60
45.60
39.90
35.30
13.60
Diluted EPS
45.60
45.60
39.90
35.30
13.60
Basic Average Shares
2,396,719.30
2,396,719.30
2,400,095.24
2,399,334.97
2,406,419.12
Diluted Average Shares
2,396,719.30
2,396,719.30
2,400,095.24
2,399,334.97
2,406,419.12
Rent Expense Supplemental
--
--
734,300
588,700
535,400
Total Expenses
395,304,800
395,304,800
373,280,900
340,015,100
303,264,000
Net Income from Continuing & Discontinued Operation
109,290,400
109,290,400
95,763,800
84,735,800
32,727,300
Normalized Income
114,770,646.16
114,770,646.16
100,065,264.81
86,386,834.68
67,435,683.21
Interest Income
--
--
10,229,100
3,845,400
5,533,700
Interest Expense
2,313,600
2,313,600
2,384,700
1,720,000
1,273,500
Net Interest Income
-2,313,600
-2,313,600
-2,384,700
2,125,400
-1,273,500
EBIT
139,834,900
139,834,900
113,263,600
95,804,300
46,086,700
EBITDA
165,588,800
165,588,800
138,830,000
121,108,600
67,524,100
Reconciled Cost of Revenue
107,473,600
107,473,600
106,626,100
119,424,200
103,515,400
Reconciled Depreciation
25,753,900
25,753,900
25,566,400
25,304,300
21,437,400
Net Income from Continuing Operation Net Minority Interest
109,290,400
109,290,400
95,763,800
84,735,800
32,727,300
Total Unusual Items Excluding Goodwill
-6,778,500
-6,778,500
-4,943,200
-1,814,500
-45,668,700
Total Unusual Items
-6,778,500
-6,778,500
-4,943,200
-1,814,500
-45,668,700
Normalized EBITDA
172,367,300
172,367,300
143,773,200
122,923,100
113,192,800
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,298,253.84
-1,298,253.84
-641,735.19
-163,465.32
-10,960,316.79
3/31/2022 - 1/3/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LUPIN.BO Lupin Limited
2,000.35
-1.08%
 
CIPLA.BO Cipla Limited
1,505.40
+0.22%
 
ORCHPHARMA.BO Orchid Pharma Limited
713.85
-1.16%
 
ERIS.BO Eris Lifesciences Limited
1,794.30
+0.23%
 
GLENMARK.BO Glenmark Pharmaceuticals Limited
1,669.70
+1.95%
 
SIGACHI.BO Sigachi Industries Limited
58.43
+1.72%
 
DRREDDY.BO Dr. Reddy's Laboratories Limited
1,361.45
-0.12%
 
SHILPAMED.BO Shilpa Medicare Limited
986.15
+2.17%
 
GRANULES.BO Granules India Limited
509.45
-2.75%
 
AUROPHARMA.BO Aurobindo Pharma Limited
1,150.65
-0.38%